LYMPHOCYTE PERCENTAGE DECREASED side effect
What is LYMPHOCYTE PERCENTAGE DECREASED ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
LYMPHOCYTE PERCENTAGE DECREASED and Recently Reported Side Effects
LYMPHOCYTE PERCENTAGE DECREASED and 15 most Active Side Effect polls
LYMPHOCYTE PERCENTAGE DECREASED and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with LYMPHOCYTE PERCENTAGE DECREASED
FLOVENT ISONIAZID KEPPRA MABTHERA NAMENDA NATALIZUMAB PREDNISOLONE RIFAMPICIN SEROQUEL TAXOL TEMODAR VELCADEFlovent Side Effects Report #5455121-1
Consumer or non-health professional from JAPAN reported FLOVENT problem on Sept 03, 2007. Female patient, 61 years of age, was diagnosed with asthma and was treated with FLOVENT. After drug was administered, patient experienced the following problems/side effects: eosinophilic cellulitis, lymphocyte percentage decreased, marrow hyperplasia, neutrophil percentage increased, platelet count decreased, scab, white blood cell count increased, . FLOVENT dosage: unknown. Patient recovered.
Taxol Side Effects Report #5361761-0
TAXOL problem was reported by a Physician from JAPAN on June 18, 2007. Female patient, 66 years of age, was diagnosed with ovarian cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: injection site reaction, lymphocyte percentage decreased, malignant neoplasm progression, metastases to spleen, metastasis, monocyte percentage decreased, myelodysplastic syndrome, neutrophil percentage increased, platelet count decreased, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN. Patient recovered.
Prednisolone Side Effects Report #5332834-3
Physician from KOREA, REPUBLIC OF reported PREDNISOLONE problem on May 04, 2007. Male patient, 38 years of age, was diagnosed with dermatomyositis and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus chorioretinitis, lymphocyte percentage decreased, neutrophil percentage increased, . PREDNISOLONE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, HYDROXYCHLOROQUINE SULPHATE, IMMUNOGLOBULIN, ORAPRED. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5598789-1
TEMODAR problem was reported by a Physician from UNITED STATES on Jan 14, 2008. Male patient, 57 years of age, weighting 197.3 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, disseminated intravascular coagulation, lymphocyte percentage decreased, multi-organ failure, pneumocystis jiroveci pneumonia, sepsis, thrombocytopenia, . TEMODAR dosage: 100 MG/M2;QD;PO. During the same period patient was treated with CELEBREX, DEXAMETHASONE, PREVACID, TAGAMET, CALCITRIOL, CHLOROQUIN, ENALAPRIL MALEATE. Patient was hospitalized. Patient died on 12/23/2007.
Namenda Side Effects Report #5590861-5
Health Professional from UNITED STATES reported NAMENDA problem on Oct 18, 2006. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with NAMENDA. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, ileus, lymphocyte percentage decreased, rash pruritic, red blood cell morphology abnormal, . NAMENDA dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, ACETAMINOPHEN, ZOLOFT, LOPRESSOR, LOMOTIL, NEXIUM, REGLAN, WELCHOL. Patient was hospitalized. Patient recovered.
Seroquel Side Effects Report #5490747-0
SEROQUEL problem was reported by a Physician from PORTUGAL on Oct 09, 2007. Female patient, 57 years of age, was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: blood creatinine decreased, leukocytosis, lymphocyte percentage decreased, muscle rigidity, neuroleptic malignant syndrome, neutrophil percentage increased, rhabdomyolysis, . SEROQUEL dosage: unknown. During the same period patient was treated with LORAZEPAM, VENLAFAXINE, MIRTAZAPINE. Patient was hospitalized. Patient recovered.
Isoniazid Side Effects Report #5494891-3
Consumer or non-health professional from JAPAN reported ISONIAZID problem on Oct 09, 2007. Female patient, 73 years of age, was treated with ISONIAZID. After drug was administered, patient experienced the following problems/side effects: condition aggravated, lymphocyte count decreased, lymphocyte percentage decreased, mycobacterium abscessus infection, neutrophil count decreased, pathogen resistance, . ISONIAZID dosage: 300 MG, QD,. During the same period patient was treated with PYRAZINAMIDE, RIFAMPICIN, ETHAMBUTOL HYDROCHLORIDE. Patient recovered.
Velcade Side Effects Report #5713678-7
VELCADE problem was reported by a Health Professional from UNITED STATES on Apr 09, 2008. Female patient, 66 years of age, weighting 104.1 lb, was diagnosed with amyloidosis and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, granulocyte count increased, lymphocyte percentage decreased, mitral valve incompetence, oedema peripheral, pyrexia, skin ulcer, urinary tract infection, white blood cell count increased, . VELCADE dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with DARVOCET, PREDNISONE, MEGACE, CARVEDILOL. Patient was hospitalized. Patient recovered.
Rifampicin Side Effects Report #5374139-0
Consumer or non-health professional from JAPAN reported RIFAMPICIN problem on June 15, 2007. Female patient, 73 years of age, was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, lung infiltration, lymphocyte percentage decreased, mycobacterium abscessus infection, tuberculosis skin test positive, . RIFAMPICIN dosage: 450 MG, QD. During the same period patient was treated with ISONIAZID, PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE. Patient recovered.
Natalizumab Side Effects Report #5335608-2
NATALIZUMAB problem was reported by a Physician from UNITED STATES on May 08, 2007. Male patient, 45 years of age, weighting 198.0 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal strangulated hernia, b-cell lymphoma, lymphocyte percentage decreased, monocyte percentage decreased, neutrophil percentage increased, non-hodgkin's lymphoma stage iii, platelet count decreased, tremor, umbilical hernia, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with ASPIRIN, ALLEGRA. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5271872-6
Consumer or non-health professional from FRANCE reported MABTHERA problem on Mar 06, 2007. Female patient, 64 years of age, weighting 132.3 lb, was diagnosed with t-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, lung disorder, lymphocyte percentage decreased, neutropenia, neutrophil percentage decreased, red blood cell count decreased, white blood cell count decreased, . MABTHERA dosage: 700 MG, UNK; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5281255-0
KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on Mar 09, 2007. Female patient, 51 years of age, weighting 116.8 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, condition aggravated, lymphocyte percentage decreased, red blood cell count decreased, white blood cell count decreased, . KEPPRA dosage: 500 MG 4/D PO. During the same period patient was treated with DOXYCYCLIN, LEVOTHYROXINE, NEXIUM, KALINOR. Patient was hospitalized. Patient recovered.